ISRCTN81331696已完成未知
Fluvastatin in the therapy of acute coronary syndrome
ovartis Pharma CR s.r.o.0 个研究点目标入组 1,000 人开始时间: 2005年3月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
- 2005 results in http://www.ncbi.nlm.nih.gov/pubmed/15790413 2. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20500832
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Eligible patients with ST elevation ACS must have resting chest pain less than 12 hours before admission and either >1 mm ST-segment elevation in 2 or more continuous leads or new left bundle branch block on electrocardiogram (ECG). Those with non-ST elevation ACS must have resting chest pain during the previous 48 hours and either >1 mm ST segment depression or negative T waves in 2 or more continuous leads.
排除标准
- •Does not match inclusion criteria
研究者
相似试验
已完成
4 期
Fluvastatin in the Therapy of Acute Coronary SyndromeCoronary DiseaseMyocardial InfarctionNCT00171275Novartis1,000
已完成
4 期
Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)Actue Coronary SyndromesNCT00382460Bristol-Myers Squibb4,000
尚未招募
4 期
Collaborative Trial of Fluvastatin on Atrial FibrillatioJPRN-UMIN000000582CO-FAT study group300
已完成
2 期
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome PatientsAntiphospholipid SyndromeNCT00674297Hospital for Special Surgery, New York41
Unknown
4 期
Fluvastatin After Heart TransplantationHeart TransplantationHypercholesterolemiaNCT00421005University of Bologna56